Disease-specific outcomes assessment for diagnosis of colorectal neoplasia

From clinical trials to community practice

Douglas Rex, R. M. Ness

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Maximizing the outcomes of any diagnostic or treatment strategy translated from clinical trials to community practice is a complex process. Certainly, this is true of screening and diagnostic strategies for colorectal cancer and polyps. First, clinicians must identify clinical trials with valid results. Second, questions should be posed regarding whether the population in community practice is similar to that of the study population in the clinical trial, whether the methodology of the trial is or can be reproduced in the community setting, and whether the individuals performing the strategies have comparable training and expertise to those in the clinical trial. Most importantly, monitoring the performance of the strategies in community practice identifies areas of strength and weakness and allows for decision making that optimizes patient outcomes.

Original languageEnglish
Pages (from-to)697-704
Number of pages8
JournalGastrointestinal Endoscopy Clinics of North America
Volume9
Issue number4
StatePublished - 1999

Fingerprint

Outcome Assessment (Health Care)
Clinical Trials
Neoplasms
Polyps
Population
Colorectal Neoplasms
Decision Making
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Disease-specific outcomes assessment for diagnosis of colorectal neoplasia : From clinical trials to community practice. / Rex, Douglas; Ness, R. M.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 9, No. 4, 1999, p. 697-704.

Research output: Contribution to journalArticle

@article{13ab2ab66c33465eb0a7806c5978a601,
title = "Disease-specific outcomes assessment for diagnosis of colorectal neoplasia: From clinical trials to community practice",
abstract = "Maximizing the outcomes of any diagnostic or treatment strategy translated from clinical trials to community practice is a complex process. Certainly, this is true of screening and diagnostic strategies for colorectal cancer and polyps. First, clinicians must identify clinical trials with valid results. Second, questions should be posed regarding whether the population in community practice is similar to that of the study population in the clinical trial, whether the methodology of the trial is or can be reproduced in the community setting, and whether the individuals performing the strategies have comparable training and expertise to those in the clinical trial. Most importantly, monitoring the performance of the strategies in community practice identifies areas of strength and weakness and allows for decision making that optimizes patient outcomes.",
author = "Douglas Rex and Ness, {R. M.}",
year = "1999",
language = "English",
volume = "9",
pages = "697--704",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Disease-specific outcomes assessment for diagnosis of colorectal neoplasia

T2 - From clinical trials to community practice

AU - Rex, Douglas

AU - Ness, R. M.

PY - 1999

Y1 - 1999

N2 - Maximizing the outcomes of any diagnostic or treatment strategy translated from clinical trials to community practice is a complex process. Certainly, this is true of screening and diagnostic strategies for colorectal cancer and polyps. First, clinicians must identify clinical trials with valid results. Second, questions should be posed regarding whether the population in community practice is similar to that of the study population in the clinical trial, whether the methodology of the trial is or can be reproduced in the community setting, and whether the individuals performing the strategies have comparable training and expertise to those in the clinical trial. Most importantly, monitoring the performance of the strategies in community practice identifies areas of strength and weakness and allows for decision making that optimizes patient outcomes.

AB - Maximizing the outcomes of any diagnostic or treatment strategy translated from clinical trials to community practice is a complex process. Certainly, this is true of screening and diagnostic strategies for colorectal cancer and polyps. First, clinicians must identify clinical trials with valid results. Second, questions should be posed regarding whether the population in community practice is similar to that of the study population in the clinical trial, whether the methodology of the trial is or can be reproduced in the community setting, and whether the individuals performing the strategies have comparable training and expertise to those in the clinical trial. Most importantly, monitoring the performance of the strategies in community practice identifies areas of strength and weakness and allows for decision making that optimizes patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=0032717051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032717051&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 697

EP - 704

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 4

ER -